Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
IBS Complex is a nutraceutical food supplement candidate developed by AronPharma for the management of Irritable Bowel Syndrome (IBS). The formulation is a combination of polyphenol-rich extracts, prebiotics, and hydrolyzed fiber designed to provide comprehensive gastrointestinal support. Its mechanism of action involves the synergistic effect of these components: polyphenols (likely derived from Aronia melanocarpa) provide antioxidant and anti-inflammatory benefits, prebiotics promote the growth of beneficial gut microbiota, and hydrolyzed fiber aids in regulating bowel movements and improving stool consistency. The product is currently undergoing clinical evaluation to demonstrate its efficacy in reducing IBS-related symptoms and improving overall digestive function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on IBS Complex.